Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
GTF2A1 antisense RNA 1 (GTF2A1-AS1) is a human long non-coding RNA (lncRNA) located on chromosome 14, transcribed antisense to the GTF2A1 (General Transcription Factor IIA Subunit 1) gene[1][8][3]. As an antisense RNA, it is classified as a long non-coding RNA with no known protein-coding capacity. The specific function of GTF2A1-AS1 has not been functionally characterized and there is no direct evidence that it serves as a therapeutic target, biomarker, or safety concern[1][8][7]. Its presumed function is likely related to the regulation of GTF2A1 or other local or networked transcriptomic effects via antisense or epigenetic mechanisms, as is common with lncRNAs[1][10]. There are currently no drugs known to interact with GTF2A1-AS1, nor is there evidence for a specific disease role, although lncRNAs as a class have been associated with diverse biological functions and diseases.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on GTF2A1 antisense RNA 1 (GTF2A1-AS1).